P370 Endoscopic balloon dilatation in paediatric stricturing Crohn’s disease: A retrospective collaborative study of the paediatric IBD Porto group of ESPGHAN
O. Ledder1, J. Viala2, D. Urlep3, D. Serban4, L. De Ridder5, M. Martinelli6, C. Romano7, S. Oliva8, S. Sharma9, M. Thomson9, D. Turner1, Paediatric IBD Porto Group of ESPGHAN
1Department of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel, 2Department of paediatric gastroenterology, Hôpitaux de Paris, Paris, France, 3Department of Paediatric Gastroenterology, Ljubljana University Medical Centre, Ljubljana, Slovenia, 4Emergency Clinical Hospital for Children, 2nd Clinic of Pediatrics, Cluj-Napoca, Romania, 5Department of Paediatric Gastroenterology, Erasmus MC/Sophia Children′s Hospital, Rotterdam, The Netherlands, 6Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy, 7Department of Paediatric Gastroenterology, University of Messina, Messina, Italy, 8Department of Paediatric Gastroenterology, Sapienza University of Rome, Rome, Italy, 9Department of Paediatric Gastroenterology, Sheffield Children’s Hospital, Sheffield, UK
Background
Endoscopic balloon dilatation (EBD) is an effective management strategy in stricturing Crohn’s disease (CD). While adult studies showed a high success rate of improved symptoms and avoiding surgical intervention, very little has been published in children. We thus present a multi-centre retrospective cohort study of EBD in paediatric CD from 9 centres affiliated with the Paediatric IBD Porto group of ESPGHAN.
Methods
Demographics, imaging, serological data, clinical indices (including the newly-developed modified CD obstructive score (mCDOS)), post-EBD complications and need for surgical intervention were recorded on electronic case report forms.
Results
Thirty-nine balloon dilatations were performed on 34 children (20 (59%) male, mean age 14.3 ± 3.4 years, median disease duration 3.5 years (IQR 1.1–5.8)). Successful avoidance of surgical intervention was recorded in 26 (76%) children, during a median follow-up period of 24 weeks (IQR 8–24). There was an increase in number of patients in clinical remission (wPCDAI < 12.5) following EBD from 20% pre-dilation to 36% (ns), 53% (
Conclusion
EBD is an effective and safe technique in paediatric stricturing CD with over 75% avoiding surgery by one year and 8% complications. Further data are required to better identify optimal stricture features and dilatation diameter in children.